Therapeutic Approaches in Small Cell Lung Cancer

Jacob Sands, MD, a physician at Dana-Farber Cancer Institute, as well as instructor of medicine at Harvard Medical School, provides a comprehensive review of the small cell lung cancer treatment paradigm, and how COVID-19 has limited treatment opportunities and continuation in patients.

EP: 1.Introducing the Post-Pandemic Change With Lung Cancer Screening

EP: 2.Opportunities and Challenges With Lung Cancer Screening Following COVID-19

EP: 3.How to Reduce Lung Cancer Screening Disparities After COVID-19

EP: 4.The Effects of COVID-19 and Vaccinations in Non–Small Cell Lung Cancer

Now Viewing

EP: 5.Therapeutic Approaches in Small Cell Lung Cancer

EP: 6.2021 USPSTF Lung Cancer Screening Recommendations

EP: 7.Concluding Remarks in Lung Cancer Screening Following COVID-19

Jacob Sands, MD, a physician at Dana-Farber Cancer Institute, as well as instructor of medicine at Harvard Medical School, provides a comprehensive review of the small cell lung cancer treatment paradigm, and how COVID-19 has limited treatment opportunities and continuation in patients.

Related Videos